s6y
Company name or ticker
Search
Oruka Therapeutics, Inc.
424B7
Prospectus filed pursuant to Rule 424(b)(7)
Filed
Tuesday, April 21, 2026
Accession number
0001213900-26-046194
Documents
PROSPECTUS SUPPLEMENT
424B7
On sec.gov
Filing index
All files
Complete submission text
SGML header